CONMED CORPORATION Defined Benefit Plan, Expected Return (Loss) on Plan Assets
CONMED CORPORATION (CNMD) reported Defined Benefit Plan, Expected Return (Loss) on Plan Assets of $1.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets · last filed 2026-07-29
- CONMED CORPORATION defined benefit plan, expected return (loss) on plan assets for the quarter ending 2026-06-30 was $1.15M, a 5.77% increase year-over-year.
- CONMED CORPORATION defined benefit plan, expected return (loss) on plan assets for the quarter ending 2025-12-31 was $1.09M, a 1.18% decline year-over-year.
- CONMED CORPORATION defined benefit plan, expected return (loss) on plan assets for the quarter ending 2025-09-30 was $1.09M, a 0.91% decline year-over-year.
- CONMED CORPORATION defined benefit plan, expected return (loss) on plan assets for the quarter ending 2025-06-30 was $1.09M, a 0.91% decline year-over-year.
- CONMED CORPORATION defined benefit plan, expected return (loss) on plan assets for fiscal 2025 was $4.36M, a 0.98% decline from fiscal 2024.
- CONMED CORPORATION defined benefit plan, expected return (loss) on plan assets for fiscal 2024 was $4.41M, a 6.66% increase from fiscal 2023.
- CONMED CORPORATION defined benefit plan, expected return (loss) on plan assets for fiscal 2023 was $4.13M, a 22.00% decline from fiscal 2022.
- CONMED CORPORATION defined benefit plan, expected return (loss) on plan assets for fiscal 2022 was $5.29M, a 2.72% increase from fiscal 2021.
| Period end | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 3 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 6 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 9 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.15M 10-Q · filed 2026-07-29 | $2.31M 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.18M derived: sum of 2 quarters · filed 2026-02-17 | $3.27M derived: sum of 3 quarters · filed 2026-07-29 | $4.36M 10-K · filed 2026-02-17 |
| 2025-09-30 | $1.09M 10-Q · filed 2025-11-06 | $2.18M derived: sum of 2 quarters · filed 2026-07-29 | $3.27M 10-Q · filed 2025-11-06 | $4.38M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.09M 10-Q · filed 2026-07-29 | $2.18M 10-Q · filed 2026-07-29 | $3.28M derived: sum of 3 quarters · filed 2026-07-29 | $4.38M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $1.09M 10-Q · filed 2025-05-01 | $2.19M derived: sum of 2 quarters · filed 2026-02-17 | $3.29M derived: sum of 3 quarters · filed 2026-02-17 | $4.39M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.20M derived: sum of 2 quarters · filed 2026-02-17 | $3.30M derived: sum of 3 quarters · filed 2026-02-17 | $4.41M 10-K · filed 2026-02-17 |
| 2024-09-30 | $1.10M 10-Q · filed 2025-11-06 | $2.20M derived: sum of 2 quarters · filed 2025-11-06 | $3.30M 10-Q · filed 2025-11-06 | $4.34M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $1.10M 10-Q · filed 2025-07-31 | $2.20M 10-Q · filed 2025-07-31 | $3.24M derived: sum of 3 quarters · filed 2026-02-17 | $4.27M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-01 | $2.13M derived: sum of 2 quarters · filed 2026-02-17 | $3.17M derived: sum of 3 quarters · filed 2026-02-17 | $4.20M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.07M derived: sum of 2 quarters · filed 2026-02-17 | $3.10M derived: sum of 3 quarters · filed 2026-02-17 | $4.13M 10-K · filed 2026-02-17 |
| 2023-09-30 | $1.03M 10-Q · filed 2024-10-31 | $2.06M derived: sum of 2 quarters · filed 2024-10-31 | $3.10M 10-Q · filed 2024-10-31 | $4.42M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.03M 10-Q · filed 2024-08-01 | $2.06M 10-Q · filed 2024-08-01 | $3.39M derived: sum of 3 quarters · filed 2025-02-18 | $4.71M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.03M 10-Q · filed 2024-04-25 | $2.35M derived: sum of 2 quarters · filed 2025-02-18 | $3.68M derived: sum of 3 quarters · filed 2025-02-18 | $5.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $2.65M derived: sum of 2 quarters · filed 2025-02-18 | $3.97M derived: sum of 3 quarters · filed 2025-02-18 | $5.29M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.32M 10-Q · filed 2023-10-26 | $2.65M derived: sum of 2 quarters · filed 2023-10-26 | $3.97M 10-Q · filed 2023-10-26 | $5.26M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.32M 10-Q · filed 2023-07-27 | $2.65M 10-Q · filed 2023-07-27 | $3.94M derived: sum of 3 quarters · filed 2024-02-28 | $5.22M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.32M 10-Q · filed 2023-04-27 | $2.61M derived: sum of 2 quarters · filed 2024-02-28 | $3.90M derived: sum of 3 quarters · filed 2024-02-28 | $5.19M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.58M derived: sum of 2 quarters · filed 2024-02-28 | $3.87M derived: sum of 3 quarters · filed 2024-02-28 | $5.16M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.29M 10-Q · filed 2022-10-27 | $2.58M derived: sum of 2 quarters · filed 2022-10-27 | $3.87M 10-Q · filed 2022-10-27 | $5.12M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $1.29M 10-Q · filed 2022-07-28 | $2.58M 10-Q · filed 2022-07-28 | $3.83M derived: sum of 3 quarters · filed 2023-02-21 | $5.09M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $1.29M 10-Q · filed 2022-05-05 | $2.54M derived: sum of 2 quarters · filed 2023-02-21 | $3.80M derived: sum of 3 quarters · filed 2023-02-21 | $5.05M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $2.51M derived: sum of 2 quarters · filed 2023-02-21 | $3.77M derived: sum of 3 quarters · filed 2023-02-21 | $5.02M 10-K · filed 2023-02-21 |
| 2020-09-30 | $1.25M 10-Q · filed 2021-10-28 | $2.51M derived: sum of 2 quarters · filed 2021-10-28 | $3.77M 10-Q · filed 2021-10-28 | $4.95M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $1.25M 10-Q · filed 2021-07-29 | $2.51M 10-Q · filed 2021-07-29 | $3.69M derived: sum of 3 quarters · filed 2022-02-22 | $4.87M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $1.25M 10-Q · filed 2021-04-29 | $2.44M derived: sum of 2 quarters · filed 2022-02-22 | $3.62M derived: sum of 3 quarters · filed 2022-02-22 | $4.80M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $2.36M derived: sum of 2 quarters · filed 2022-02-22 | $3.54M derived: sum of 3 quarters · filed 2022-02-22 | $4.72M 10-K · filed 2022-02-22 |
| 2019-09-30 | $1.18M 10-Q · filed 2020-10-29 | $2.36M derived: sum of 2 quarters · filed 2020-10-29 | $3.54M 10-Q · filed 2020-10-29 | $4.90M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $1.18M 10-Q · filed 2020-07-30 | $2.36M 10-Q · filed 2020-07-30 | $3.72M derived: sum of 3 quarters · filed 2021-02-22 | $5.07M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $1.18M 10-Q · filed 2020-04-30 | $2.54M derived: sum of 2 quarters · filed 2021-02-22 | $3.89M derived: sum of 3 quarters · filed 2021-02-22 | $5.24M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $2.71M derived: sum of 2 quarters · filed 2021-02-22 | $4.06M derived: sum of 3 quarters · filed 2021-02-22 | $5.42M 10-K · filed 2021-02-22 |
| 2018-09-30 | $1.35M 10-Q · filed 2019-10-31 | $2.71M derived: sum of 2 quarters · filed 2019-10-31 | $4.06M 10-Q · filed 2019-10-31 | $5.39M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $1.35M 10-Q · filed 2019-08-01 | $2.71M 10-Q · filed 2019-08-01 | $4.03M derived: sum of 3 quarters · filed 2020-02-24 | $5.36M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $1.35M 10-Q · filed 2019-04-26 | $2.68M derived: sum of 2 quarters · filed 2020-02-24 | $4.00M derived: sum of 3 quarters · filed 2020-02-24 | $5.33M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $2.65M derived: sum of 2 quarters · filed 2020-02-24 | $3.98M derived: sum of 3 quarters · filed 2020-02-24 | $5.30M 10-K · filed 2020-02-24 |
| 2017-09-30 | $1.32M 10-Q · filed 2018-11-02 | $2.65M derived: sum of 2 quarters · filed 2018-11-02 | $3.98M 10-Q · filed 2018-11-02 | $5.27M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $1.32M 10-Q · filed 2018-08-02 | $2.65M 10-Q · filed 2018-08-02 | $3.95M derived: sum of 3 quarters · filed 2019-02-25 | $5.24M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $1.32M 10-Q · filed 2018-04-26 | $2.62M derived: sum of 2 quarters · filed 2019-02-25 | $3.92M derived: sum of 3 quarters · filed 2019-02-25 | $5.22M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $2.59M derived: sum of 2 quarters · filed 2019-02-25 | $3.89M derived: sum of 3 quarters · filed 2019-02-25 | $5.19M 10-K · filed 2019-02-25 |
| 2016-09-30 | $1.30M 10-Q · filed 2017-11-02 | $2.59M derived: sum of 2 quarters · filed 2017-11-02 | $3.89M 10-Q · filed 2017-11-02 | $5.32M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $1.30M 10-Q · filed 2017-07-27 | $2.59M 10-Q · filed 2017-07-27 | $4.02M derived: sum of 3 quarters · filed 2018-02-26 | $5.44M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $1.30M 10-Q · filed 2017-04-27 | $2.72M derived: sum of 2 quarters · filed 2018-02-26 | $4.14M derived: sum of 3 quarters · filed 2018-02-26 | $5.53M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $2.85M derived: sum of 2 quarters · filed 2018-02-26 | $4.23M derived: sum of 3 quarters · filed 2018-02-26 | $5.70M 10-K · filed 2018-02-26 |
| 2015-09-30 | $1.42M 10-Q · filed 2016-10-28 | $2.80M derived: sum of 2 quarters · filed 2016-10-28 | $4.27M 10-Q · filed 2016-10-28 | $2.08M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $1.38M 10-Q · filed 2016-07-28 | $2.85M 10-Q · filed 2016-07-28 | $657.00K derived: sum of 3 quarters · filed 2017-02-27 | $2.15M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $1.47M 10-Q · filed 2016-05-02 | -$723.00K derived: sum of 2 quarters · filed 2017-02-27 | $773.00K derived: sum of 3 quarters · filed 2017-02-27 | $2.27M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$696.00K derived: sum of 2 quarters · filed 2017-02-27 | $800.00K derived: sum of 3 quarters · filed 2017-02-27 | $2.30M 10-K · filed 2017-02-27 |
| 2014-09-30 | $1.50M 10-Q · filed 2015-10-23 | $2.99M derived: sum of 2 quarters · filed 2015-10-23 | $4.49M 10-Q · filed 2015-10-23 | $6.07M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $1.50M 10-Q · filed 2015-07-27 | $2.99M 10-Q · filed 2015-07-27 | $4.58M derived: sum of 3 quarters · filed 2016-02-23 | $5.88M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $1.50M 10-Q · filed 2015-04-24 | $3.08M derived: sum of 2 quarters · filed 2016-02-23 | $4.38M derived: sum of 3 quarters · filed 2016-02-23 | $5.68M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $2.89M derived: sum of 2 quarters · filed 2016-02-23 | $4.19M derived: sum of 3 quarters · filed 2016-02-23 | $5.49M 10-K · filed 2016-02-23 |
| 2013-09-30 | $1.30M 10-Q · filed 2014-10-24 | $2.60M derived: sum of 2 quarters · filed 2014-10-24 | $3.91M 10-Q · filed 2014-10-24 | $5.09M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $1.30M 10-Q · filed 2014-07-25 | $2.60M 10-Q · filed 2014-07-25 | $3.79M derived: sum of 3 quarters · filed 2015-02-23 | $4.92M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $1.32M 10-Q · filed 2014-04-25 | $2.49M derived: sum of 2 quarters · filed 2015-02-23 | $3.62M derived: sum of 3 quarters · filed 2015-02-23 | $4.75M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $2.30M derived: sum of 2 quarters · filed 2015-02-23 | $3.43M derived: sum of 3 quarters · filed 2015-02-23 | $4.57M 10-K · filed 2015-02-23 |
| 2012-09-30 | $1.13M 10-Q · filed 2013-10-28 | $2.26M derived: sum of 2 quarters · filed 2013-10-28 | $3.39M 10-Q · filed 2013-10-28 | $4.49M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $1.13M 10-Q · filed 2013-07-29 | $2.26M 10-Q · filed 2013-07-29 | $3.36M derived: sum of 3 quarters · filed 2014-02-24 | $4.45M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $1.13M 10-Q · filed 2013-04-29 | $2.23M derived: sum of 2 quarters · filed 2014-02-24 | $3.32M derived: sum of 3 quarters · filed 2014-02-24 | $4.45M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $2.19M derived: sum of 2 quarters · filed 2014-02-24 | $3.32M derived: sum of 3 quarters · filed 2014-02-24 | $4.38M 10-K · filed 2014-02-24 |
| 2011-09-30 | $1.09M 10-Q · filed 2012-10-29 | $2.23M derived: sum of 2 quarters · filed 2012-10-29 | $3.28M 10-Q · filed 2012-10-29 | |
| 2011-06-30 | $1.13M 10-Q · filed 2012-07-30 | $2.19M 10-Q · filed 2012-07-30 | ||
| 2011-03-31 | $1.06M 10-Q · filed 2012-05-01 | |||
| 2010-12-31 | $4.23M 10-K · filed 2013-02-25 | |||
| 2009-12-31 | $3.82M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |